Cabozantinib Free Base
To Order Contact us: lieven@wlsolutions.be
Cabozantinib hydrochloride (849217-68-1 (free base)) |
||
MBS5751609-25mg | 25mg | EUR 235 |
Cabozantinib hydrochloride (849217-68-1 (free base)) |
||
MBS5751609-2mg | 2mg | EUR 145 |
Cabozantinib hydrochloride (849217-68-1 (free base)) |
||
MBS5751609-50mg | 50mg | EUR 305 |
Cabozantinib hydrochloride (849217-68-1 (free base)) |
||
MBS5751609-5mg | 5mg | EUR 155 |
Cabozantinib |
||
abx282883-100g | 100 µg | Ask for price |
Cabozantinib |
||
abx282883-20g | 20 µg | EUR 143.75 |
Cabozantinib |
||
abx282883-50g | 50 µg | EUR 325 |
Cabozantinib |
||
HY-13016 | 10mM/1mL | EUR 411.26 |
Description: Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035, and 1.3 nM, respectively. Cabozantinib displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib shows antiangiogenic activity. Cabozantinib disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis[1][2]. |
Cabozantinib |
||
GW6378 | 10mg | EUR 670.31 |
Cabozantinib |
||
GW6378-10 | 10 | EUR 232 |
Cabozantinib |
||
GW6378-50 | 50 | EUR 650.4 |
Cabozantinib |
||
MBS3606163-100mg | 100mg | EUR 260 |
Cabozantinib |
||
MBS3606163-10mg | 10mg | EUR 215 |
Cabozantinib |
||
MBS3606163-200mg | 200mg | EUR 325 |
Cabozantinib |
||
MBS3606163-50mg | 50mg | EUR 225 |
Cabozantinib |
||
MBS3606163-5mg | 5mg | EUR 210 |
Cabozantinib |
||
T2586-10mg | 10mg | Ask for price |
Description: Cabozantinib |
Cabozantinib |
||
T2586-1g | 1g | Ask for price |
Description: Cabozantinib |
Cabozantinib |
||
T2586-1mg | 1mg | Ask for price |
Description: Cabozantinib |
Cabozantinib |
||
T2586-50mg | 50mg | Ask for price |
Description: Cabozantinib |
Cabozantinib |
||
T2586-5mg | 5mg | Ask for price |
Description: Cabozantinib |
Cabozantinib-d6 |
||
HY-13016S | 10 mg | EUR 3787.94 |
Description: Cabozantinib-d6 is the deuterium labeled Cabozantinib. Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively[1][2][3]. |
Cabozantinib-d4 |
||
HY-13016S1 | Get quote | Ask for price |
Description: Cabozantinib-d4 is deuterium labeled Cabozantinib. Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively. |
Cabozantinib, XL184 |
||
20-abx182391 |
|
|
XL184 (Cabozantinib) |
||
E1KS1119 | 10mg1 PHYSICAL AND CHEMICAL PROPERTIES | EUR 362.4 |
XL184 (Cabozantinib) |
||
MBS8506340-10mg | 10mg | EUR 440 |
XL184 (Cabozantinib) |
||
MBS8506340-5x10mg | 5x10mg | EUR 1835 |
Cabozantinib malate |
||
123216 | 25.0mg | EUR 150 |
Cabozantinib malate |
||
GP4726 | 100mg | EUR 1189.15 |
Cabozantinib malate |
||
GP4726-1 | 1 | EUR 1138.9 |
Cabozantinib malate |
||
GP4726-100 | 100 | EUR 197.7 |
Cabozantinib malate |
||
GP4726-500 | 500 | EUR 702.7 |
Cabozantinib N-oxide |
||
C051600 | 10mg | EUR 1740 |
Description: 1621681-63-7 |
2-Hydroxy Cabozantinib |
||
H273960 | 250mg | EUR 1200 |
Description: 1628530-38-0 |
Cabozantinib (S-malate) |
||
HY-12044 | 10mM/1mL | EUR 135.28 |
Description: Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively. |
Cabozantinib (S-malate) |
||
MBS3600498-100mg | 100mg | EUR 275 |
Cabozantinib (S-malate) |
||
MBS3600498-10mg | 10mg | EUR 220 |
Cabozantinib (S-malate) |
||
MBS3600498-200mg | 200mg | EUR 365 |
Cabozantinib (S-malate) |
||
MBS3600498-50mg | 50mg | EUR 245 |
Cabozantinib (S-malate) |
||
MBS3600498-5mg | 5mg | EUR 210 |
Cabozantinib S-malate |
||
MBS386720-100mg | 100mg | EUR 260 |
Cabozantinib S-malate |
||
MBS386720-500mg | 500mg | EUR 640 |
Cabozantinib S-malate |
||
MBS386720-50mg | 50mg | EUR 185 |
Cabozantinib S-malate |
||
MBS386720-5x500mg | 5x500mg | EUR 2875 |
Cabozantinib S-malate |
||
T1797-10mg | 10mg | Ask for price |
Description: Cabozantinib S-malate |
Cabozantinib S-malate |
||
T1797-1g | 1g | Ask for price |
Description: Cabozantinib S-malate |
Cabozantinib S-malate |
||
T1797-1mg | 1mg | Ask for price |
Description: Cabozantinib S-malate |
Cabozantinib S-malate |
||
T1797-50mg | 50mg | Ask for price |
Description: Cabozantinib S-malate |
Cabozantinib S-malate |
||
T1797-5mg | 5mg | Ask for price |
Description: Cabozantinib S-malate |
Cabozantinib (hydrochloride) |
||
HY-13016A | Get quote | Ask for price |
Description: Cabozantinib hydrochloride is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035 and 1.3 nM, respectively. Cabozantinib hydrochloride displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib hydrochloride shows antiangiogenic activity. Cabozantinib hydrochloride disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis[1]. |
Cabozantinib hydrochloride |
||
MBS3609940-10mg | 10mg | EUR 245 |
Cabozantinib hydrochloride |
||
MBS3609940-25mg | 25mg | EUR 305 |
Cabozantinib hydrochloride |
||
MBS3609940-2mg | 2mg | EUR 200 |
Cabozantinib hydrochloride |
||
MBS3609940-50mg | 50mg | EUR 370 |
Cabozantinib hydrochloride |
||
MBS3609940-5mg | 5mg | EUR 215 |
Cabozantinib hydrochloride |
||
T5164-10mg | 10mg | Ask for price |
Description: Cabozantinib hydrochloride |
Cabozantinib hydrochloride |
||
T5164-1g | 1g | Ask for price |
Description: Cabozantinib hydrochloride |
Cabozantinib hydrochloride |
||
T5164-1mg | 1mg | Ask for price |
Description: Cabozantinib hydrochloride |
Cabozantinib hydrochloride |
||
T5164-50mg | 50mg | Ask for price |
Description: Cabozantinib hydrochloride |
Cabozantinib hydrochloride |
||
T5164-5mg | 5mg | Ask for price |
Description: Cabozantinib hydrochloride |
Cabozantinib malate (XL184) |
||
B1401-100 | 100 mg | EUR 148 |
Description: Tyrosine Kinase|c-MET |
Cabozantinib malate (XL184) |
||
B1401-25 | 25 mg | EUR 160 |
Description: Tyrosine Kinase|c-MET |
Cabozantinib malate (XL184) |
||
B1401-5 | 5 mg | EUR 56 |
Description: Tyrosine Kinase|c-MET |
Cabozantinib malate (XL184) |
||
B1401-5.1 | 10 mM (in 1mL DMSO) | EUR 80 |
Description: Tyrosine Kinase|c-MET |
XL184(Cabozantinib malate) |
||
MBS577954-100mg | 100mg | EUR 215 |
XL184(Cabozantinib malate) |
||
MBS577954-10mg | 10mg | EUR 160 |
XL184(Cabozantinib malate) |
||
MBS577954-200mg | 200mg | EUR 300 |
XL184(Cabozantinib malate) |
||
MBS577954-50mg | 50mg | EUR 180 |
XL184(Cabozantinib malate) |
||
MBS577954-5mg | 5mg | EUR 145 |
Cabozantinib Hydrogen Sulfate |
||
C051620 | 25mg | EUR 1800 |
Description: 1628530-40-4 |
Cabozantinib L-Malate Salt |
||
C051500 | 10mg | EUR 259 |
Description: 1140909-48-3 |
Cabozantinib L-Malate Salt |
||
MBS6081381-100mg | 100mg | EUR 565 |
Cabozantinib L-Malate Salt |
||
MBS6081381-25mg | 25(mg | EUR 305 |
Cabozantinib L-Malate Salt |
||
MBS6081381-50mg | 50mg | EUR 425 |
Cabozantinib L-Malate Salt |
||
MBS6081381-5x100mg | 5x100(mg | EUR 2390 |
Cabozantinib (XL184, BMS-907351) |
||
A2977-100 | 100 mg | EUR 544 |
Description: Tyrosine Kinase|Axl#Tyrosine Kinase|c-MET#Tyrosine Kinase|FLT3 |
Cabozantinib (XL184, BMS-907351) |
||
A2977-25 | 25 mg | EUR 160 |
Description: Tyrosine Kinase|Axl#Tyrosine Kinase|c-MET#Tyrosine Kinase|FLT3 |
Cabozantinib (XL184, BMS-907351) |
||
A2977-5 | 5 mg | EUR 56 |
Description: Tyrosine Kinase|Axl#Tyrosine Kinase|c-MET#Tyrosine Kinase|FLT3 |
Cabozantinib (XL184, BMS-907351) |
||
A2977-5.1 | 10 mM (in 1mL DMSO) | EUR 60 |
Description: Tyrosine Kinase|Axl#Tyrosine Kinase|c-MET#Tyrosine Kinase|FLT3 |
Cabozantinib (XL184, BMS-907351) |
||
A2977-S | Evaluation Sample | EUR 24 |
Description: Tyrosine Kinase|Axl#Tyrosine Kinase|c-MET#Tyrosine Kinase|FLT3 |
Cabozantinib (XL184, BMS-907351) |
||
MBS576075-100mg | 100mg | EUR 180 |
Cabozantinib (XL184, BMS-907351) |
||
MBS576075-10mg | 10mg | EUR 150 |
Cabozantinib (XL184, BMS-907351) |
||
MBS576075-200mg | 200mg | EUR 225 |